Aliases & Classifications for Hydrarthrosis

MalaCards integrated aliases for Hydrarthrosis:

Name: Hydrarthrosis 12 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:528
ICD9CM 35 719.08
SNOMED-CT 68 156579009 202370001

Summaries for Hydrarthrosis

MalaCards based summary : Hydrarthrosis is related to synovitis and arthritis, and has symptoms including arthralgia, edema and metatarsalgia. An important gene associated with Hydrarthrosis is MEFV (MEFV, Pyrin Innate Immunity Regulator), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Development Endothelin-1/EDNRA signaling. The drugs Infliximab and Celecoxib have been mentioned in the context of this disorder. Affiliated tissues include bone, and related phenotypes are homeostasis/metabolism and hematopoietic system

Related Diseases for Hydrarthrosis

Diseases related to Hydrarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 68)
# Related Disease Score Top Affiliating Genes
1 synovitis 29.5 IL1B IL1RN IL6 MMP3
2 arthritis 29.1 IL1B IL1RN IL6 MMP3
3 intermittent hydrarthrosis 12.4
4 systemic onset juvenile idiopathic arthritis 10.7 IL1B MEFV
5 cervical adenitis 10.6 IL1B MEFV
6 periostitis 10.6 IL1RN SLCO2A1
7 familial cold autoinflammatory syndrome 1 10.6 IL1B MEFV
8 vulvar vestibulitis syndrome 10.5 IL1B IL1RN
9 gastric cancer, hereditary diffuse 10.4 IL1B IL1RN
10 schnitzler syndrome 10.4 IL1B IL1RN
11 cinca syndrome 10.4 IL1B IL1RN MEFV
12 recurrent corneal erosion 10.3 IL1B IL6
13 cryopyrin-associated periodic syndrome 10.3 IL1RN IL6
14 acute cholangitis 10.3 IL1RN IL6
15 familial mediterranean fever 10.3 IL1B IL1RN MEFV
16 bagassosis 10.3 IL1B IL6
17 periodontitis, chronic 10.3 IL1B IL6
18 epilepsy, familial temporal lobe, 2 10.2 C4A PARP1
19 cerebral artery occlusion 10.2 IL1B IL1RN
20 hypersensitivity reaction type iii disease 10.2 C4A IL6 MEFV
21 uremic pruritus 10.2 IL1B IL6
22 brucellosis 10.2 IL1RN IL6 MEFV
23 funisitis 10.2 IL1B IL6
24 palindromic rheumatism 10.1 IL1B MEFV PRTN3
25 glossitis 10.1 IL1B IL6
26 pericarditis 10.1 IL1B IL6 MEFV
27 leptospirosis 10.1 AQP1 IL1B IL6
28 primary bacterial infectious disease 10.1 IL1B IL6 MEFV
29 euthyroid sick syndrome 10.1 IL1B IL6
30 frozen shoulder 10.1 ASIC2 ASIC3 IL1B MMP3
31 brain edema 10.1 AQP1 IL1B IL6
32 laryngitis 10.1 IL1B IL6
33 anca-associated vasculitis 10.0 IL6 PRTN3
34 osteosclerotic myeloma 10.0 IL1B IL1RN IL6
35 aortic aneurysm, familial abdominal, 1 10.0 IL1B IL6 MMP3
36 dengue shock syndrome 10.0 IL1B IL1RN IL6
37 idiopathic neutropenia 10.0 IL1B IL1RN IL6
38 aggressive periodontitis 10.0 IL1B IL1RN IL6
39 polyarteritis nodosa 10.0 IL6 MEFV PRTN3
40 periodontitis 10.0 IL1B IL6 MMP3
41 autoinflammation, lipodystrophy, and dermatosis syndrome 10.0 IL1B IL1RN IL6
42 ascaris lumbricoides infection 10.0 IL1B IL6
43 osteomyelitis 10.0 IL1B IL1RN IL6
44 juvenile rheumatoid arthritis 9.9 IL1B IL1RN IL6
45 hypersensitivity vasculitis 9.9 C4A MEFV
46 psoriatic arthritis 9.9 IL1B IL6 MMP3
47 peritonitis 9.9 AQP1 IL1B IL6 MEFV
48 acute vascular insufficiency of intestine 9.9 IL1B IL6
49 glomerulonephritis 9.9 C4A IL1B PRTN3
50 osteoarthritis 9.8

Graphical network of the top 20 diseases related to Hydrarthrosis:



Diseases related to Hydrarthrosis

Symptoms & Phenotypes for Hydrarthrosis

UMLS symptoms related to Hydrarthrosis:


arthralgia, edema, metatarsalgia, effusion of joint, other specified sites, other symptoms referable to joint, painful swollen joints, stiffness of joint, not elsewhere classified in icd10cm

MGI Mouse Phenotypes related to Hydrarthrosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.1 SLCO2A1 PARP1 AQP9 MAPK3 ASIC3 MEFV
2 hematopoietic system MP:0005397 10.07 PRTN3 PARP1 AQP9 MAPK3 MEFV IL1B
3 cardiovascular system MP:0005385 10.03 SLCO2A1 AQP3 IL6 ASIC2 MAPK3 IL1B
4 immune system MP:0005387 9.96 PRTN3 MMP3 PARP1 AQP3 AQP9 MAPK3
5 hearing/vestibular/ear MP:0005377 9.88 PARP1 MAPK3 ASIC2 ASIC3 AQP1 AQP3
6 integument MP:0010771 9.7 PARP1 IL6 MAPK3 ASIC3 MEFV IL1B
7 skeleton MP:0005390 9.56 MMP3 IL6 AQP3 MAPK3 MEFV IL1B
8 vision/eye MP:0005391 9.17 PARP1 IL6 AQP3 ASIC2 MAPK3 ASIC3

Drugs & Therapeutics for Hydrarthrosis

Drugs for Hydrarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 98)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Infliximab Approved Phase 4 170277-31-3
2
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
3
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
4
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
5
Liraglutide Approved Phase 4 204656-20-2 44147092
6
Glucosamine Approved, Investigational, Nutraceutical Phase 4 3416-24-8 439213
7 Prednisolone acetate Phase 4
8 Analgesics Phase 4
9 glucocorticoids Phase 4
10 Methylprednisolone acetate Phase 4
11 Methylprednisolone Hemisuccinate Phase 4
12 Gastrointestinal Agents Phase 4,Phase 3
13 Neuroprotective Agents Phase 4
14 Cyclooxygenase 2 Inhibitors Phase 4
15 Cyclooxygenase Inhibitors Phase 4
16 Analgesics, Non-Narcotic Phase 4
17 Hormone Antagonists Phase 4
18 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
19 Hormones Phase 4
20 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
21 Peripheral Nervous System Agents Phase 4
22 Prednisolone hemisuccinate Phase 4
23 Prednisolone phosphate Phase 4
24 Antiemetics Phase 4
25 Protective Agents Phase 4,Phase 1,Not Applicable
26 Anti-Inflammatory Agents Phase 4,Phase 3
27 Anti-Inflammatory Agents, Non-Steroidal Phase 4
28 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
29 Autonomic Agents Phase 4
30 Antineoplastic Agents, Hormonal Phase 4
31 Hypoglycemic Agents Phase 4
32 Incretins Phase 4
33
Chondroitin Nutraceutical Phase 4 9007-27-6 53477707
34
Abatacept Approved Phase 3 332348-12-6 10237
35
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
36
Formaldehyde Approved, Vet_approved Phase 3 50-00-0 712
37
Adalimumab Approved Phase 3 331731-18-1 16219006
38
Aluminum hydroxide Approved, Investigational Phase 3 21645-51-2
39
leucovorin Approved, Nutraceutical Phase 3,Phase 2,Phase 1 58-05-9 143 6006
40
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
41
Vitamin D3 Approved, Nutraceutical Phase 3 67-97-0 6221 5280795
42
Ergocalciferol Approved, Nutraceutical Phase 3 50-14-6 5280793
43
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1 59-30-3 6037
44 Adjuvants, Immunologic Phase 3,Phase 1,Not Applicable
45 Micronutrients Phase 3,Phase 1
46 Folic Acid Antagonists Phase 3,Phase 2,Phase 1
47 Trace Elements Phase 3,Phase 1
48 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
49 Vaccines Phase 3
50 Antacids Phase 3

Interventional clinical trials:

(show all 40)
# Name Status NCT ID Phase Drugs
1 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Completed NCT01144143 Phase 4 Infliximab;Placebo;Standard of Care: Methylprednisolone acetate
2 Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis Completed NCT01425853 Phase 4 Chondroitin/Glucosamine (Droglican);Celecoxib
3 Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance Active, not recruiting NCT02931383 Phase 4 Liraglutide 3 mg (Saxenda);Liraglutide 3 mg placebo
4 A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography Completed NCT00767325 Phase 3 Abatacept;Methotrexate
5 Ross River Virus (RRV) Vaccine Study Completed NCT01242670 Phase 3
6 VItamin D Effect on Osteoarthritis Study Completed NCT01176344 Phase 3 Vitamin D;Placebo
7 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease Completed NCT00195715 Phase 3
8 Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis Recruiting NCT02837146 Phase 3 Methotrexate (MTX)
9 Somatosensory Stimulation in Knee Osteoarthritis Unknown status NCT02854176 Phase 2
10 Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee Unknown status NCT02554240 Phase 2 DA-5202 20mg;DA-5202 10mg;Na Hyaluronate 20mg
11 Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage Completed NCT02219113 Phase 1, Phase 2
12 Effects of Ultrasound Therapy on Cartilage Healing in Patients With Knee Osteoarthritis Completed NCT00931749 Phase 2
13 Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study Recruiting NCT02263638 Phase 2 Anakinra
14 Effectiveness and Safety of Autologous ADRC for Treatment of Anterior Cruciate Ligament Partial Rupture Enrolling by invitation NCT02469792 Phase 1, Phase 2
15 Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy Enrolling by invitation NCT02827851 Phase 2
16 Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) Terminated NCT01569152 Phase 2 MK-8457 100 mg;Dose-Matched Placebo;Methotrexate
17 Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma Completed NCT00742924 Phase 1 cisplatin;dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;zoledronic acid;Mesna
18 Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients Unknown status NCT00658060
19 Determination of Adipocytokine in Synovial Fluid of Osteoarthritis Patients Unknown status NCT01993342
20 Use of Infrared Spectroscopy in Septic Arthritis Diagnosis Completed NCT02860871
21 The Effects of Joint Effusion on Proprioception Completed NCT01060215 Not Applicable
22 Effects of Joint Effusion on Quadriceps Muscle Completed NCT01314820 Not Applicable
23 MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs Completed NCT00584311 Not Applicable
24 Ultrasonography Assessment of Septic Arthritis on Native Joint Completed NCT02018952 Not Applicable
25 Association Between Clinical Signs and MRI Findings of the Lumbar Facet Joints Completed NCT01628939
26 Chikungunya Arthritis in the Americas Completed NCT02463968
27 Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet Completed NCT01677416
28 Time Difference Between Onsets of Lateral And Medial Hamstring Muscles During Gait in Patients With Patellofemoral Pain. Completed NCT03392688 Not Applicable
29 An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST) Completed NCT01394276
30 Effect of Yogurts Supplemented With Mobilee on Joint Function in Healthy Individuals With Joint Discomfort Completed NCT01303432 Not Applicable
31 Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis Completed NCT03203408 Not Applicable
32 Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis Recruiting NCT03327584 Not Applicable
33 Pilot Trial to Assess the Feasibility of Implementing Objective Parameters in Patients Affected by Knee Osteoarthritis Recruiting NCT03421054 Not Applicable
34 Ultrasonography in Hemophilic Joint Disease and Serum Markers Recruiting NCT02634918
35 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients Active, not recruiting NCT01850719 Not Applicable
36 Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss Active, not recruiting NCT02931370
37 Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab Active, not recruiting NCT03557853 Golimumab Injection
38 Outcome Study of Highly-cross Linked Polyethylene vs. Standard Polyethylene for Primary Posterior Stabilized (PS) Total Knee Enrolling by invitation NCT02178020
39 Efficacy and Safety of b-2Cool on Adults With Joint Discomfort Not yet recruiting NCT02843620 Not Applicable
40 Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis Withdrawn NCT00836394 Not Applicable

Search NIH Clinical Center for Hydrarthrosis

Genetic Tests for Hydrarthrosis

Anatomical Context for Hydrarthrosis

MalaCards organs/tissues related to Hydrarthrosis:

41
Bone

Publications for Hydrarthrosis

Articles related to Hydrarthrosis:

(show all 38)
# Title Authors Year
1
Boiogito, a Kampo medicine, improves hydrarthrosis in a rat model of knee osteoarthritis. ( 26703073 )
2015
2
Successful Treatment of Intermittent Hydrarthrosis With Hydroxychloroquine. ( 26587859 )
2015
3
Pathological findings from synovium of early osteoarthritic knee joints with persistent hydrarthrosis. ( 24837400 )
2014
4
Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation. ( 22887853 )
2013
5
May some cases of intermittent hydrarthrosis represent an atypical form of calcium pyrophosphate dihydrate crystal deposition disease? Usefulness of mutational analysis of the MEFV gene. ( 17889261 )
2008
6
Association of intermittent hydrarthrosis with MEFV gene mutations. ( 16802374 )
2006
7
Successful therapy with low-dose colchicine in intermittent hydrarthrosis. ( 12595650 )
2003
8
Multicentric reticulohistiocytosis with hydrarthrosis in both knee joints: disease stabilization with synovectomy, and medication with a steroid and low-dose methotrexate. ( 24383904 )
2002
9
Comparison between clinical evaluation and ultrasonography in detecting hydrarthrosis of the knee. ( 10606382 )
1999
10
Analysis of synovial fluid components of hydrarthrosis in long-term hemodialysis patients. ( 10370156 )
1999
11
Intermittent hydrarthrosis. ( 11273267 )
1998
12
Hydrarthrosis of the knee or ankle revealing metaphyseal stress fractures of the tibia. A report of 3 cases. ( 8523370 )
1995
13
Hyaluronan, cartilage destruction and hydrarthrosis in traumatic arthritis. ( 11548232 )
1994
14
The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SV. ( 2098221 )
1990
15
Participation of synovial mast cells in intermittent hydrarthrosis. ( 2467680 )
1989
16
Treatment of hydrarthrosis of the knee with manual manipulation and herbs. ( 3246884 )
1988
17
Calcium pyrophosphate crystals in intermittent hydrarthrosis. ( 3029370 )
1986
18
LE cells in intermittent hydrarthrosis. ( 6157396 )
1980
19
Periodic synoviosis (intermittent hydrarthrosis) with observations and studies on a patient. ( 4464498 )
1974
20
Tarsal hydrarthrosis in the horse: response to intra-articular injection of synthetic steroids. ( 5815590 )
1969
21
Evaluation of intra-articular injection of synthetic steroids in tarsal hydrarthrosis in cattle. ( 5691642 )
1968
22
Tarsal hydrarthrosis (bog spavin) in the horse: blood, serum, and synovial fluid findings. ( 5688981 )
1968
23
Therapeutic management of tarsal hydrarthrosis (bog spavin) in the horse by intra-articular injection of prednisolone. ( 6068578 )
1967
24
Characteristics of blood, serum, and synovial effusions in cattle with tarsal hydrarthrosis. ( 6069486 )
1967
25
Intra-articular injection of 6 alpha-methyl, 17 alpha-hydroxyprogesterone acetate in tarsal hydrarthrosis (bog spavin) in the horse. ( 5624181 )
1967
26
Acute Cervical Hydrarthrosis. ( 19790510 )
1964
27
SYPHILITIC HYDRARTHROSIS. ( 14075738 )
1963
28
Intermittent hydrarthrosis; periodic benign synovitis. ( 13567199 )
1958
29
Intermittent hydrarthrosis. ( 13383213 )
1957
30
Periodic benign synovitis; idiopathic intermittent hydrarthrosis. ( 13367081 )
1956
31
Hodgkin's disease presenting as hydrarthrosis of knee. ( 14378634 )
1955
32
Intermittent hydrarthrosis. ( 14372871 )
1955
33
Intermittent hydrarthrosis. ( 14933539 )
1952
34
Intermittent hydrarthrosis; two cases. ( 15390577 )
1949
35
The roentgenographic appearance of temporomandibular hydrarthrosis. ( 21018447 )
1946
36
Idiopathic Hydrarthrosis. ( 19988486 )
1932
37
Intermittent Hydrarthrosis: (Hydrops Intermittens Articulorum). ( 21433466 )
1930
38
Chronic Hydrarthrosis. ( 19976537 )
1913

Variations for Hydrarthrosis

Expression for Hydrarthrosis

Search GEO for disease gene expression data for Hydrarthrosis.

Pathways for Hydrarthrosis

Pathways related to Hydrarthrosis according to GeneCards Suite gene sharing:

(show all 16)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.14 IL1B IL1RN IL6 MAPK3 MMP3 PRTN3
2
Show member pathways
12.44 ASIC2 ASIC3 IL1B MAPK3 PARP1
3
Show member pathways
12.11 IL1B IL6 MAPK3 MMP3
4
Show member pathways
11.98 IL1B IL1RN IL6 MAPK3
5 11.88 C4A IL1B IL1RN IL6
6 11.77 IL1B IL6 MMP3
7 11.7 IL1B IL6 MAPK3
8 11.64 IL1B IL6 MMP3
9 11.64 AQP1 IL1B IL6 MAPK3
10 11.61 IL1B IL6 MAPK3
11 11.49 IL1B IL6 MAPK3 MMP3
12 11.27 IL1B IL1RN IL6
13 11.14 C4A IL1B IL6 MAPK3
14 11.04 IL1B IL6 MAPK3
15 10.89 IL1B MAPK3
16
Show member pathways
10.72 IL1B IL6 MAPK3 MMP3

GO Terms for Hydrarthrosis

Cellular components related to Hydrarthrosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 basolateral plasma membrane GO:0016323 8.92 AQP1 AQP3 AQP9 ENSG00000250424

Biological processes related to Hydrarthrosis according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 transmembrane transport GO:0055085 9.96 AQP1 AQP3 AQP9 ENSG00000250424 SLCO2A1
2 inflammatory response GO:0006954 9.77 C4A IL1B IL1RN IL6 MEFV
3 interleukin-1-mediated signaling pathway GO:0070498 9.72 IL1B IL1RN MAPK3
4 cellular response to mechanical stimulus GO:0071260 9.69 AQP1 IL1B MAPK3
5 cation transmembrane transport GO:0098655 9.65 AQP1 ASIC2 ASIC3
6 positive regulation of histone acetylation GO:0035066 9.58 IL1B MAPK3
7 cellular response to nitric oxide GO:0071732 9.57 AQP1 MMP3
8 cytokine-mediated signaling pathway GO:0019221 9.55 IL1B IL1RN IL6 MMP3 PRTN3
9 response to acidic pH GO:0010447 9.54 ASIC2 ASIC3
10 ammonium transmembrane transport GO:0072488 9.52 AQP1 ENSG00000250424
11 positive regulation of histone phosphorylation GO:0033129 9.49 IL1B MAPK3
12 fever generation GO:0001660 9.46 IL1B IL1RN
13 negative regulation of interleukin-1-mediated signaling pathway GO:2000660 9.43 IL1RN IL6
14 sensory perception of sour taste GO:0050915 9.4 ASIC2 ASIC3
15 detection of mechanical stimulus involved in sensory perception GO:0050974 9.32 ASIC2 ASIC3
16 carbon dioxide transmembrane transport GO:0035378 9.26 AQP1 ENSG00000250424
17 glycerol transport GO:0015793 9.13 AQP1 AQP3 AQP9
18 water transport GO:0006833 8.92 AQP1 AQP3 AQP9 ENSG00000250424

Molecular functions related to Hydrarthrosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 interleukin-1 receptor binding GO:0005149 9.48 IL1B IL1RN
2 ligand-gated sodium channel activity GO:0015280 9.46 ASIC2 ASIC3
3 ammonium transmembrane transporter activity GO:0008519 9.43 AQP1 ENSG00000250424
4 urea transmembrane transporter activity GO:0015204 9.4 AQP3 AQP9
5 water transmembrane transporter activity GO:0005372 9.37 AQP1 AQP9
6 acid-sensing ion channel activity GO:0044736 9.32 ASIC2 ASIC3
7 glycerol channel activity GO:0015254 9.26 AQP3 AQP9
8 channel activity GO:0015267 9.26 AQP1 AQP3 AQP9 ENSG00000250424
9 carbon dioxide transmembrane transporter activity GO:0035379 9.16 AQP1 ENSG00000250424
10 water channel activity GO:0015250 8.92 AQP1 AQP3 AQP9 ENSG00000250424

Sources for Hydrarthrosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....